Larvol Delta - A-Study-to-Evaluate-ALNAGT01-RVR-in-Adult-Patients-With-Mild-to-Moderate-Hypertension-Pretreated-With-Zilebesiran

ALN-AGT01 RVR - Alnylam

zilebesiran (ALN-AGT) - Alnylam, Roche

http://clinicaltrials.gov/ct2/show/NCT07553442

May 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next